A BIOLOGICAL PERSPECTIVE FOR THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY TESTOSTERONE

被引:8
作者
Cojocaru, Cristian [1 ,2 ]
Turcanu, Adina [2 ]
Mihaescu, Traian [1 ,2 ]
Ciobica, Alin [3 ,4 ]
Timofte, Daniel [1 ]
Alexinschi, Ovidiu [1 ]
Anton, Emil [1 ]
Cojocaru, Elena [1 ,5 ]
机构
[1] Grigore T Popa Univ Med & Pharm, Iasi 700115, Romania
[2] Clin Pulm Dis, Iasi, Romania
[3] Alexandru Ioan Cuza Univ, Iasi, Romania
[4] Romanian Acad, Iasi Branch, Ctr Biomed Res, Bucharest, Romania
[5] Netconsult Labs, Iasi, Romania
关键词
testosterone; chronic obstructive pulmonary disease; management; ANDROGENS; MEN;
D O I
10.2298/ABS140407035C
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chronic obstructive pulmonary disease (COPD) is mainly characterized by a chronically poor airflow that worsens over time. COPD is believed to be a bio-pathological entity with unclear boundaries that affects the rest of the body through various pathophysiological mechanisms. There have been recent discussions regarding the possible relevance of various hormones such testosterone in the management of COPD. In our paper, we decided to study this possible relevance by comparing the levels of testosterone in COPD patients with an age-matched control group in order to see if testosterone levels may act as an important parameter for the functional disability and deterioration in the management of COPD. Our analysis showed a significant decrease (p= 0.001) in the specific concentrations of testosterone in the serum of the COPD group, as compared to the control. Although our results suggest that testosterone is in fact decreased in COPD, there is still an absence of sufficient evidence to draw firm conclusions about its long-term benefits and risks in the management in COPD.
引用
收藏
页码:257 / 259
页数:3
相关论文
共 15 条
  • [1] Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
    Atlantis, Evan
    Fahey, Paul
    Cochrane, Belinda
    Wittert, Gary
    Smith, Sheree
    [J]. BMJ OPEN, 2013, 3 (08):
  • [2] Medical progress: Chronic obstructive pulmonary disease.
    Barnes, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) : 269 - 280
  • [3] Serum testosterone and depressive symptoms in severe OSA patients
    Bercea, R. M.
    Patacchioli, F. R.
    Ghiciuc, C. M.
    Cojocaru, E.
    Mihaescu, T.
    [J]. ANDROLOGIA, 2013, 45 (05) : 345 - 350
  • [4] Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease
    Casaburi, R
    Bhasin, S
    Cosentino, L
    Porszasz, J
    Somfay, A
    Lewis, MI
    Fournier, M
    Storer, TW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) : 870 - 878
  • [5] Chronic obstructive pulmonary disease
    Decramer, Marc
    Janssens, Wim
    Miravitlles, Marc
    [J]. LANCET, 2012, 379 (9823) : 1341 - 1351
  • [6] Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168
  • [7] Genes and Chronic Obstructive Pulmonary Disease
    Foreman, Marilyn G.
    Campos, Michael
    Celedon, Juan C.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (04) : 699 - +
  • [8] Antioxidants and human disease: A general introduction
    Halliwell, B
    [J]. NUTRITION REVIEWS, 1997, 55 (01) : S44 - S49
  • [9] Jimenez-Ruiz C A, 2013, Monaldi Arch Chest Dis, V79, P33
  • [10] Endocrinological derangements in COPD
    Laghi, F.
    Adiguzel, N.
    Tobin, M. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (04) : 975 - 996